Advertisement
Canada markets closed
  • S&P/TSX

    21,969.24
    +83.86 (+0.38%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CAD/USD

    0.7316
    -0.0007 (-0.10%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • Bitcoin CAD

    86,083.29
    -2,089.07 (-2.37%)
     
  • CMC Crypto 200

    1,304.48
    -92.06 (-6.59%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • RUSSELL 2000

    2,002.00
    +20.88 (+1.05%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • NASDAQ

    15,927.90
    +316.14 (+2.03%)
     
  • VOLATILITY

    15.03
    -0.34 (-2.21%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     

Abingdon Health First Half 2024 Earnings: UK£0.004 loss per share (vs UK£0.008 loss in 1H 2023)

Abingdon Health (LON:ABDX) First Half 2024 Results

Key Financial Results

  • Revenue: UK£2.41m (up 117% from 1H 2023).

  • Net loss: UK£1.21m (loss narrowed by 50% from 1H 2023).

  • UK£0.004 loss per share (improved from UK£0.008 loss in 1H 2023).

earnings-and-revenue-history
AIM:ABDX Earnings and Revenue History March 18th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Abingdon Health shares are up 20% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 4 warning signs for Abingdon Health (3 are significant!) that you need to be mindful of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.